MiLaboratories is a biotech company developing proprietary software to profile a person's immune picture on a DNA level.
MiLaboratories' key product - MiXCR is a top-notch solution to analyze immunology sequencing data. Software is used in the vaccine, cancer, antibodies, and autoimmune diseases drug development pipelines. The original idea is based on a Nature Journal article published in 2015 and developed by founders into a cutting-edge software solution based on competitors' reviews by top Pharma and the academic community.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 17, 2022 | Seed | $2.35M | 1 |
Speedinvest
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Speedinvest
|
Yes | Seed |